User:Ann Taylor/GLP-1 agonists
From Proteopedia
(Difference between revisions)
(→GLP-1 agonists) |
|||
| Line 1: | Line 1: | ||
==GLP-1 agonists== | ==GLP-1 agonists== | ||
| - | <StructureSection load=' | + | <StructureSection load='7KI0' size='340' side='right' caption='Caption for this structure' scene='GLP-1 bound to receptor complex'> |
| - | Glucagon-like peptide agonists (GLP) are used to treat type 2 diabetes and obesity <ref>PMID:38639549</ref>. | + | <scene name='10/1043704/Glp-1_peptide/1'>Glucagon-like peptide agonists</scene> (GLP) are used to treat type 2 diabetes and obesity <ref>PMID:38639549</ref>. |
</StructureSection> | </StructureSection> | ||
| + | |||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 16:05, 25 April 2024
GLP-1 agonists
| |||||||||||
References
- ↑ Drake T, Landsteiner A, Langsetmo L, MacDonald R, Anthony M, Kalinowski C, Ullman K, Billington CJ, Kaka A, Sultan S, Wilt TJ. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians. Ann Intern Med. 2024 Apr 19. PMID:38639549 doi:10.7326/M23-1490
